107-46-0 | Sigma-Aldrich

Periodic table A4

45 102.91 1964 3695 1.45 Rh 0, 1, 2, 3, 4, 5 [Kr] 4d85s1 46 106.42 1554.8 2963 1.30 Pd 0, 2, 4 [Kr] 4d10 47 107.87 961.78 2162 1.42

Periodic table Poster

45 102.91 1964 3695 1.45 Rh 0, 1, 2, 3, 4, 5 [Kr] 4d85s1 46 106.42 1554.8 2963 1.30 Pd 0, 2, 4 [Kr] 4d10 47 107.87 961.78 2162 1.42

JULABO Catalog 2011 en

.37 -- 20 0.5 0 ... 2.5 8 ... 11 46 x 61 x 49 9 600 123 FC1200S -15 ... +80 ±0.2 1.2 1.2

Drug Discovery Products & Services - Volume 1, 2014

Akt/PKB (Ser473) 46-601/46-677 Singleplex - phospho Phospho Akt/PKB (Thr308) 46-645 Singleplex - phospho Phospho ATF2 (Thr69/71) 46-658/46-676 Singleplex - phospho Phospho Bad (Ser112) 46-694 Singleplex

7-plex RTK Mitogenesis Total Protein Magnetic Bead Kit

c-Met 100% 0% 0% 0% 0.07% 0% 0% EGFR 0.09% 100% 0% 0% 0.08% 0% 0% ErbB2 0.03% 0.08% 100% 0% 0% 0% 0% IGF1R 0% 0% 0% 100% 0.23% 0% 0% IR 0% 0% 0%

Fast GC-A Practical Guide for Increasing Sample Throughput without Sacrificing Quality

nonadecanoate (C19:0) 25. Methyl cis-9,10-methyleneoctadecanoate (C19:0D) 26. Methyl eicosanoate (C20:0) IS C13:0 1. C14:0 2. C15:0 3. C16:0 4. C16:1n7 5. C17:0 6. C16:3n4 7. C18:0 8. C18:1n9 9. C18:

Protocol: Human Bcl-2 Family Apoptosis Panel 2 4-plex Magnetic Bead Kit

te in Bcl-xL 100% 0% 0% 0% 1% 0% BAD 0% 100% 4% 0% 0% 0% Mcl-1 0% 0% 100% 0% 0% 1% BIM 0% 0% 0% 100% 0%

Human Bcl-2 Family Apoptosis Panel 1 6-plex Magnetic Bead Kit

te in Bcl-xL 100% 0% 0% 0% 1% 0% BAD 0% 100% 4% 0% 0% 0% Mcl-1 0% 0% 100% 0% 0% 1% BIM 0% 0% 0% 100% 0%

Protocol- 48-682MAG

te in Bcl-xL 100% 0% 0% 0% 1% 0% BAD 0% 100% 4% 0% 0% 0% Mcl-1 0% 0% 100% 0% 0% 1% BIM 0% 0% 0% 100% 0%

User Guide - 4104

PR05782w Rev 10/21 2 of 107 English Introduction Centrifree® devices rapidly and efficiently separate free from protein-bound microsolute in small volumes (0 .15–1 .0 mL) of serum, plasma, and

User Guide - 4104

PR05782w Rev 10/21 2 of 107 English Introduction Centrifree® devices rapidly and efficiently separate free from protein-bound microsolute in small volumes (0 .15–1 .0 mL) of serum, plasma, and

SULFOXIDE 107-06-2 107-06-2 123-91-1 123-91-1 71-36-3 71-36-3 71-41-0 71-23-8 78-92-2 110-80-5 109-86-4 78-83-1 67-63-0 67-63-0 123-51-3 75-07-0 75-07-0 64

10- Plex RTK Angiogenesis Phosphoprotein Magnetic Bead Kit

VEGFR1 100% 2% 0% 0% 0% 1% 0% 0% 0% 0% VEGFR2 0% 100% 0% 0% 0% 0% 0% 1% 0% 0% c-Kit 0% 0% 100% 0% 0% 0% 0% 0% 0% 0% VEGFR3 1% 2% 0% 100%

10- Plex RTK Angiogenesis Total Protein Magnetic Bead Panel

VEGFR1 100% 2% 0% 0% 0% 1% 0% 0% 0% 0% VEGFR2 0% 100% 0% 0% 0% 0% 0% 1% 0% 0% c-Kit 0% 0% 100% 0% 0% 0% 0% 0% 0% 0% VEGFR3 1% 2% 0% 100%

Applicaton Note: A new MILLIPLEX® map multiplex panel enhances simultaneous quantitation of metabolic hormones in human serum and plasma

(p g/ m L) 0 400 200 600 800 1,000 1,200 1,400 0 500 1,000 1,500 2,000 Serum (pg/mL) GIP y=0.7711x+109.2 R=0.8535 Pl as m a (p g/ m L) 0 200 100 300

Overcoming Bacterial Retention and Capacity Issues in Adjuvant Filtration

Germany: 01805 045 645 Italy: 848 845 645 Spain: 901 516 645 UK: 0870 900 46 45 For other countries across Europe, please call: +44 (0) 115 943 0840, or visit: www.millipore.com/offices. For Technical

Using a New, Fast Flow, Low Protein Binding Membrane for Sterile Filtration in Life Science Applications

m e (m L) 0 5 10 15 20 0 500 1000 1500 2000 2500 3000 Express CA GS GV PES G Time (minutes) Vo lu m e

MILLIPLEX®MAP metabolic hormones in human serum and plasma

0 200 100 300 500 400 600 800 700 900 GIP 0 10 5 15 25 20 35 30 40 GLP-1 Active 0

Product Information Sheet - CS0210

Observed: Expected Neat 2136 -- 1:2 1059 1068 99 1:4 552 534 103 1:8 231 267 87 1:16 144 134 107 1:32 76 67 113 1:64 28 33 85

Replacing the AnimalComponent in Serum

1,500,000 1,000,000 500,000 0 14,000,000 12,000,000 10,000,000 8,000,000 6,000,000 4,000,000 2,000,000 0 0 2 4 6 8 10 0 2 4 6 8 10 Days Postinoculation

An Update on Ligands for Prostanoid Receptors

115-123 (2002). 45. Li, M., et al., J. Bone Miner. Res., 18, 2033-2042 (2003). 46. Woodward, D.F., et al., Prostaglandins, 46, 371-383 (1995). 47. Keery, R.J., Lumley, P., Br. J. Pharmacol., 94, 745-754

Validation and Qualification for Durapore® Sterilizing-Grade (0.22 µm) Membrane VMF4

12 7180 GERMANY Tel. (06196) 494-0 Fax (06196) 43901 HUNGARY Tel. 01 381 0433 01 381 0434 01 209 3232 Fax 01 209 0295 INDIA Tel. (91) 80-839 46 57 Fax (91) 80-839 63 45

Protocol: Mouse Lipocalin-2/NGAL

108% 2.5 46 58 124% 1.25 23 33 141% 4 10 157 5 78 85 108% 2.5 39 48 123%

Corticotropin-Releasing Factor Receptor Antagonists- Potential Novel Therapies for Human Disease

d e r : 1 . 8 0 0 . 3 2 5 . 3 0 1 0 ( U S ) T e c h n i c a l S

User Guide - UFC8010D

af det oprindelige startmateriale Cf = filtratkoncentration PR05779w Rev 10/21 46 of 107 Kemisk kompatibilitet Amicon® Ultra-centrifugeringsanordninger er beregnede til at blive anvendt

Protocol- 48-626MAG

product) or an assay normalization control, such as the GAPDH (Cat. No. 46-667MAG) MAPmate™ or β-Tubulin (Cat. No. 46-713MAG) MAPmate™ • MAGPIX® Drive Fluid PLUS (Cat. No. 40-50030), xMAP® Sheath

User Guide - UFC801008D, UFC801024D, UFC801096D

af det oprindelige startmateriale Cf = filtratkoncentration PR05779w Rev 10/21 46 of 107 Kemisk kompatibilitet Amicon® Ultra-centrifugeringsanordninger er beregnede til at blive anvendt

User Guide - UFC9010D

af det oprindelige startmateriale Cf = filtratkoncentration PR05780w Rev 10/21 46 of 107 Kemisk kompatibilitet Amicon® Ultra-centrifugeringsanordninger er beregnede til at blive anvendt

User Guide -UFC901008D, UFC901024D, UFC901096D

af det oprindelige startmateriale Cf = filtratkoncentration PR05780w Rev 10/21 46 of 107 Kemisk kompatibilitet Amicon® Ultra-centrifugeringsanordninger er beregnede til at blive anvendt

Protein Translation 6-plex Magnetic Bead Kit

product) or an assay normalization control, such as the GAPDH (Catalog # 46-667MAG) MAPmate™ or -Tubulin (Catalog # 46-713MAG) MAPmate™ • Luminex® Sheath Fluid (20 L, EMD Millipore Catalog # 40